Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraperitoneal Irinotecan Combined With Systemic Therapy for Patients With Gastric Peritoneal Metastases: A Phase II, Multicenter Study

NCT07133490 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT07133490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07133490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraperitoneal Irinotecan Combined With Systemic Therapy for Patients With Gastric Peritoneal Metastases: A Phase II, Multicenter Study
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
October 1, 2025
Completion date
July 1, 2028
Enrollment
55 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal metastases from gastric cancer